BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20230420T170000
DTEND;TZID=America/Toronto:20230420T180000
DTSTAMP:20230403T172151Z
CREATED:20230403T172151Z
LAST-MODIFIED:20230403T172151Z
UID:24360-1682010000-1682013600@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Linda Avey
DESCRIPTION:Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics. Open to all. \nLinda Avey reflects on her career journey and how the challenges she encountered in personalized health led to the founding of 23andMe and Precisely. From consumer genetics and the quantified self-movement to AI\, Linda will share her insights and vision for the future of a digital-first health system \nThis Entrepreneurs Salon will be hosted by Isaac Kohane\, Chair\, Department of Biomedical Informatics\, Harvard Medical School. \nLinda Avey is the co-founder and CEO of Austin-based Precisely (precise.ly)\, a digital assistant for automating routine medical flows and implementing personalized\, value-based care. \nIn 2006 Linda envisioned and co-founded 23andMe\, the leading consumer genetics research company (NASDAQ: ME). Her experience in the genetics research industry\, and its need for more participants\, led to her concept of the 23andMe research model\, which links genetic data to health information from the company’s millions of users. This is now fueling the discovery of potential drug targets and landing pharmaceutical partnerships valued in the hundreds of millions USD. \nLinda is on the advisory board of Alphabet’s life science subsidiary Verily and the Board of Fellows of Stanford Medical School. She was the founding independent board director at Rock Health\, the first venture fund dedicated to digital health\, where she advised startups ideating new ways of delivering healthcare.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-linda-avey/
LOCATION:Online
END:VEVENT
END:VCALENDAR